Welcome to MiRus™ where you can expect MoRe®.

MiRus was launched in 2016 bringing novel material, hardware and software solutions to spine and orthopaedic surgery. MiRus has created a comprehensive platform centered around our proprietary MoRe® alloy to create the world's smallest, strongest and biologically superior implants. We also address the demands of today's healthcare environment with an integrated platform of pre-operative planning and risk assessment tools, a breakthrough surgical navigation and robotics system and post-operative monitoring and risk mitigation.

www.mirusmed.com

Brands: EUROPA™ Open and MIS Pedicle Screw System CYGNUS™ Anterior Cervical Plate HYPERION 3DR™ TLIF, CALLISTO 3DR™ PLIF, CALYPSO 3DR™ LLIF, RIGEL 3DR™ Cervical GALILEO™ Spine Alignment Monitoring System


 Videos

MoRe® (Molybdenum-Rhenium) Superalloy
MiRus™ Spine Implant Portfolio
GALILEO™ Spine Alignment Monitoring System

 Chat or Meet with a Representative


 Press Releases

  • News Release

          Contact:
    Mahesh Krishnan
    VP, Sales and Marketing, MiRus
    mkrishnan@mirusmed.com
    770-317-5564

    MiRus™ Announces First Clinical Use of the MiRus™ 3DR™ Printed Lumbar Interbody Fusion System

    ATLANTA — June 11, 2020—MiRus is pleased to announce that it received FDA 510(k) clearance for its 3DR™ (Randomized) Printed Lumbar Interbody Fusion System which consists of the CALLISTO 3DR™ PLIF, HYPERION 3DR™ TLIF, CALYPSO 3DR™ LLIF and the ANTARES 3DR™ ALIF.

    “The HYPERION 3DR TLIF is the first interbody with stiffness equivalent to cancellous bone, providing improved load sharing, reduced risk of subsidence and potentially superior fusion rates.” noted Alan McGee MD, Orthopaedic Surgeon at OrthoNortheast in Fort Wayne, Indiana

    MiRus currently leads the industry in innovative clinical solutions with the smallest pedicle screws, lowest profile cervical plate, and a real-time intra-operative sagittal alignment system.  With the launch of the 3DR™ Interbody System, MiRus has set the benchmark for interbodies with a stiffness of 0.53 GPa, the lowest stiffness of any interbody in the world and in the same range as cancellous bone.

    After using the new Hyperion TLIF interbody, James Mok, MD, MBA,  Orthopedic Spine Surgeon with Dupage Medical Group, Elmhurst, IL noted “the interbody has the unique combination of a big graft window, which I consider important in order to allow bridging bone that can be evaluated on x-ray, combined with the benefits of 3D printing to mimic normal bone architecture and in-growth. My practice is almost exclusively MIS and in combination with the smallest profile pedicle screws from MiRus, I am excited to have these PLIF and TLIF interbodies available because of their handling characteristics and x-ray appearance.”

    Faiz Ahmad MD, Associate Professor, Emory University Department of Neurosurgery, Atlanta observed “The unique open structure modeled after the cancellous bone promotes bony on-growth and in-growth as well as providing the largest graft volume of any interbody on the market.   I am also impressed with the low radio-density of the interbody allowing for easy postoperative visualization.”

    Jay S. Yadav MD, Founder and CEO of MiRus, stated “We have collaborated with an outstanding group of orthopaedic and neurosurgeons to develop transformative interbody solutions. With the shift in the market to 3D printed interbodies, the MiRus 3DR™ Printed Lumbar Interbody Fusion System designed with a randomized lattice structure that mimics the organic structure of bone, sets the benchmark for matching the stiffness and porosity of cancellous bone. ”

    About MiRus, LLC.

    MiRus is a medical device company that has developed and is commercializing proprietary novel biomaterials, implants and software solutions for spine, orthopaedics and cardiovascular disease.  We are addressing the demands of today's healthcare environment with an integrated platform of pre-operative planning and risk assessment tools, a breakthrough navigation and robotics system and post-operative monitoring and risk mitigation. Find more information about MiRus at www.mirusmed.com.

    Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company’s products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements.

    http://www.prnewswire.com/news-releases/mirus-announces-first-clinical-use-of-the-mirus-3dr-printed-lumbar-interbody-fusion-system-301074488.html

     * CALLISTO 3DR™, CALYPSO 3DR™, HYPERION 3DR™, ANTARES 3DR™ and MiRus™ are trademarks of MiRus, LLC.

  • News Release

          Contact:
    Mahesh Krishnan
    VP, Sales and Marketing, MiRus
    mkrishnan@mirusmed.com
    770-317-5564

    First Spine Surgeries
    Using The MoRe® Superalloy

    ATLANTA — August 30, 2019— MiRus announces successful spine surgeries at several centers across the country using the MoRe® superalloy. MiRus had received FDA 510(k) clearance for the MoRe® based Europa™ Pedicle Screw System earlier this year.

    MoRe®, a proprietary molybdenum rhenium superalloy for medical implants, provides an unprecedented combination of strength, ductility, durability, and biological safety.  The MoRe® superalloy allows for the design of a new generation of smaller, stronger, more durable, and bio-friendly pedicle screw implants that should result in less soft tissue disruption, quicker recovery and better outcomes for patients.

    “The EUROPA pedicle screw system with the 4.5mm MoRe rod has provided a valuable addition to my armamentarium” noted Matthew McGirt MD, Neurosurgeon at Carolina Neurosurgery & Spine Associates in North Carolina.  “The 4.5mm MoRe rod has allowed me to do a pedicle screw fixation with an incredibly small profile providing many benefits such as increased surface area for bone grafting, ease of interbody placement, and the ability to work on nerves around the rod and pedicle screw system. In addition, the malleability of the 4.5 MoRe rod despite its strength and durability, has been a tremendous advantage in long constructs.”

    Jason Cormier MD, Neurosurgeon at Acadiana Neurosurgery in Louisiana stated, “I have had a primarily MIS practice for years and have done thousands of cases with 20 different MIS systems, I have found the Europa pedicle screw system along with the 4.5mm MoRe alloy rod to be exceptionally beneficial to my patients in terms of recovery. The very small pedicle tulips lead to less facet pain and soft tissue disruption and the strength and fatigue resistance of the MoRe rod allows for a better overall construct.  I have found no other pedicle screw system that offers the comprehensive benefits of this system.”

    “This is a momentous event for patients, surgeons and for us,” added Jay S. Yadav MD, CEO of MiRus “as we see patients benefitting from the years of basic science research conducted by our team.”

    MiRus is fortunate to be collaborating with an outstanding worldwide group of orthopaedic and neurosurgeons in developing transformative spine solutions. Application of the MoRe® superalloy is rapidly expanding into other applications such as foot and ankle, upper extremity, CMF and cardiovascular.

    About MiRus, LLC.

    MiRus is a medical device company that has developed and is commercializing proprietary

    novel biomaterials, implants and software solutions for spine, orthopaedics and cardiovascular disease.  We are addressing the demands of today's healthcare environment with an integrated platform of pre-operative planning and risk assessment tools, a breakthrough navigation and robotics system and post-operative monitoring and risk mitigation. Find more information about MiRus at www.mirusmed.com.

    Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company’s products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements.

     https://www.prnewswire.com/news-releases/first-spine-surgeries-using-the-more-superalloy-300909762.html

     * MoRe® is a registered trademark of MiRus, LLC.  Europa™ and MiRus™ are trademarks of MiRus, LLC.

  • News Release  

    Contact:
    Mahesh Krishnan
    VP, Sales and Marketing, MiRus
    mkrishnan@mirusmed.com
    770-317-5564

     

    MiRus™ Receives FDA 510(k) Clearance for Lowest Profile CYGNUS™ Anterior Cervical Plate

     ATLANTA — July 26, 2019 / PRNewswire/—MiRus is pleased to announce recent FDA 510(k) clearance of the CYGNUS™ Anterior Cervical Plate System, the narrowest and thinnest  cervical plate on the market. The unique I-beam design and metal alloy used in the plate allows for a dramatically smaller footprint without sacrificing performance. The CYGNUS™ Anterior Cervical Plate with its narrower profile will lead to less retraction and anterior vertebral body preparation resulting in shorter operative times and minimizing risk of complications such as dysphagia and dysphonia in patients undergoing anterior cervical fusion.

    “The CYGNUS plate is remarkably thin and strong making it easy to implant with unparalleled graft visualization.”  stated Brian Scholl, MD, orthopaedic surgeon at The Orthopaedic Center, Huntsville, Alabama. “It truly represents a leap forward in implant design and metals technology”.

    Dmitri Sofianos, MD, orthopaedic surgeon at Chatham Orthopaedic Associates, Savannah, GA commented “The CYGNUS plate from MiRus is unique in almost every way. The new molybdenum alloy has allowed for a completely innovative and remarkably thin yet sturdy I-beam construction design that will not only reduce surgical implant time but improve patient outcomes."

    “The approval of the CYGNUS Anterior Cervical Plate System is yet another major accomplishment as we strive to develop products that are best in class with resolve to improve patient outcomes and provide surgeons with premium products.  I am enthusiastic to introduce a world class product into the ACDF marketplace that is well established and lacks innovative products such as the CYGNUS Anterior Cervical Plate” remarked Wayne Gray, Senior Director R&D, Implant Systems.

    About MiRus, LLC.

    MiRus is a medical device company that has developed and is commercializing proprietary novel biomaterials, implants and software solutions for spine, orthopaedics and cardiovascular disease.  We are addressing the demands of today's healthcare environment with an integrated platform of pre-operative planning and risk assessment tools, a breakthrough navigation and robotics system and post-operative monitoring and risk mitigation. Find more information about MiRus at www.mirusmed.com.

    Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company’s products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements.

     * CYGNUS™ and MiRus™ are trademarks of MiRus, LLC.

    https://www.prnewswire.com/news-releases/mirus-receives-fda-clearance-for-lowest-profile-anterior-cervical-plate-system-300891703.html?tc=eml_cleartime


 Featured Products

  • EUROPA™ Open and MIS Pedicle Screw System
    World's Smallest Open and MIS Pedicle Screw System MoRe®-inforced with Molybdenum-Rhenium...

  • System Features

    • Dual Pitch
    • 4.5mm MoRe® Rods
    • Ø 10.9mm Tulip Head Size
    • Ø 1.6mm Cannulation
    • Ø 4.5-8.5mm Screw Sizes
    • Gentle Friction Fit Tulip Heads
    • 15mm Reduction Threads Built-in
    • 60°Screw Head Angulation
    • Flange Locking Caps to Prevent Splaying
  • CYGNUS™ Anterior Cervical Plate
    Lowest Profile and Smallest Footprint Anterior Cervical Plate on the market....

  • System Features

    • Lowest Profile
    • Easy Cage Visualization
    •  Minimized Retraction

    • Locking Cover Plate
    • Shares Screw Driver
    • Easy-to-View
    • Tactile Feedback

    • Screw Angulation Over 30°

  • 3DR™ Printed Lumbar and Cervical Interbody System
    3DR Interbody system with 3D organic structure that mimics cancellous bone with a stiffness of 0.53 GPa, superior radiolucency, large graft window and higher hydrophilicity facilitating boney in-growth and on-growth....

  • System Features

    • Organic 3D Randomized Scaffold
    • 300-600µm Macro structure for bone in-growth
    • 20-60µm  Micro structure for bone on-growth
    • More hydrophilic
    • Large bone graft windows
    • Lowest Stiffness Interbodies – 0.53 GPa
    • Equivalent to Cancellous Bone
    • Superior Radiolucency

Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".